Additional file 1: of Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis

Yen-Hou Chang (Contributor)
Wai-Hou Li (Contributor)
Yi Chang (Contributor)
Chia-Wen Peng (Contributor)
Ching-Hsuan Cheng (Contributor)
Wei Pin Chang (Contributor)
Chi Mu Chuang (Contributor)

資料集

Description

Dataset for computing competing risks. (CSV 18Â kb)

可用日期	1月 1 2016
發行者	Unknown Publisher

DOI
10.6084/m9.figshare.c.3642380_d1.v1

存取資料集

https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Front-line_intraperitoneal_versus_intravenous_chemotherapy_in_stage_III-IV_epithelial_ovarian_tubal_and_peritoneal_cancer_with_minimal_residual_disease_a_competing_risk_analysis/4462352/1

1 文章

Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Chang, Y-H., Li, W-H., Chang, Y., Peng, C-W., Cheng, C-H., Chang, W. P. & Chuang, C-M., 2016, 於: BMC Cancer. 16, 1, p. 1-8 8 p.
研究成果: 雜誌貢獻 › 文章 › 同行評審
5 引文斯高帕斯（Scopus）

引用此

Chang, Y. (Contributor), Li, W. (Contributor), Chang, Y. (Contributor), Peng, C. (Contributor), Cheng, C. (Contributor), Chang, W. (Contributor), Chuang, C. (Contributor) (1月 1 2016). Additional file 1: of Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis. Unknown Publisher. 10.6084/m9.figshare.c.3642380_d1.v1

Additional file 1: of Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis

Description

DOI

存取資料集

研究成果

Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis

引用此